Shots: The approval is based on a P-III study that involves assessing Azstarys (qd) vs PBO in 150 children aged 6-12yrs. with ADHD The study showed improvement in 1EPs i.e. […]readmore
Shots: The FDA’s De novo clearance is based on five clinical studies in 600+ children diagnosed with ADHD, which demonstrated an improved measure of attention. After 4wks., one-third of children […]readmore
Shots: Eurofarma to get exclusive license rights to develop and commercialize NLS-1 Pharma’s Nalazol Therapy in Central & South America and to take care of its regulatory approval In 2002, […]readmore
Copyright © 2020 Digiqole. All Right Reserved.